Glycerophospholipid and Sphingosine- 1-phosphate Metabolism in Cardiovascular Disease: Mechanisms and Therapeutic Potential
Journal of Cardiovascular Translational Research · 2025-08 · 18 (4) · 749-761
DOI: 10.1007/s12265-025-10620-3 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cardiovascular Translational Research, online erschienen am 14.04.2025. Verfasst von Huiru Tang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Clinical Research Center, Shandong Provincial Key Medical and Health Discipline of Endocrinology, Affilia…. Hauptthemen laut MEDLINE: Lysophospholipids, Cardiovascular Diseases, Sphingosine, Glycerophospholipids. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 116 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Taishan Scholar Project of Shandong Province.
Abstract (Originalsprache)
Cardiovascular disease remains a leading cause of mortality worldwide, driven by factors such as dysregulated lipid metabolism, oxidative stress, and inflammation. Recent studies highlight the critical roles of both glycerophospholipid and sphingosine- 1-phosphate metabolism in the pathogenesis of cardiovascular disorders. However, the contributions of glycerophospholipid-derived metabolites remain underappreciated. Glycerophospholipid metabolism generates bioactive molecules that contribute to endothelial dysfunction, lipid accumulation, and cardiac cell injury while also modulating inflammatory and oxidative stress responses. Meanwhile, sphingosine- 1-phosphate is a bioactive lipid mediator that regulates vascular integrity, inflammation, and cardiac remodeling through its G-protein-coupled receptors. The convergence of these pathways presents novel therapeutic opportunities, where dietary interventions such as omega- 3 polyunsaturated fatty acids and pharmacological targeting of sphingosine- 1-phosphate receptors could synergistically mitigate cardiovascular risk. This review underscores the need for further investigation into the interplay between glycerophospholipid metabolism and sphingosine- 1-phosphate signaling to advance targeted therapies for the prevention and management of cardiovascular disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology and Metabolism, Clinical Research Center, Shandong Provincial Key Medical and Health Discipline of Endocrinology, Affiliated Hospital of Shandong Second Medical University, Weifang, China.
- Department of Endocrinology and Metabolism, Clinical Research Center, Shandong Provincial Key Medical and Health Discipline of Endocrinology, Affiliated Hospital of Shandong Second Medical University, Weifang, China. fy…
- Department of Endocrinology and Metabolism, Clinical Research Center, Shandong Provincial Key Medical and Health Discipline of Endocrinology, Affiliated Hospital of Shandong Second Medical University, Weifang, China. xi…
ORCID-Profile: Jingwen Zhang, Xiaodong Sun
Förderung
- National Natural Science Foundation of China
- Taishan Scholar Project of Shandong Province
Zitieren
APA
Tang, H., Kan, C., Zhang, K., Sheng, S., Qiu, H., Ma, Y., Wang, Y., Hou, N., Zhang, J., & Sun, X. (2025). Glycerophospholipid and Sphingosine- 1-phosphate Metabolism in Cardiovascular Disease: Mechanisms and Therapeutic Potential. Journal of Cardiovascular Translational Research, 18(4), 749-761. https://doi.org/10.1007/s12265-025-10620-3
Vancouver
Tang H, Kan C, Zhang K, Sheng S, Qiu H, Ma Y, et al. Glycerophospholipid and Sphingosine- 1-phosphate Metabolism in Cardiovascular Disease: Mechanisms and Therapeutic Potential. Journal of Cardiovascular Translational Research. 2025;18(4):749-761. doi:10.1007/s12265-025-10620-3
BibTeX
@article{Tang2025,
author = {Tang, Huiru and Kan, Chengxia and Zhang, Kexin and Sheng, Sufang and Qiu, Hongyan and Ma, Yujie and Wang, Yuqun and Hou, Ningning and Zhang, Jingwen and Sun, Xiaodong},
title = {Glycerophospholipid and Sphingosine- 1-phosphate Metabolism in Cardiovascular Disease: Mechanisms and Therapeutic Potential},
journal = {Journal of Cardiovascular Translational Research},
year = {2025},
volume = {18},
number = {4},
pages = {749--761},
doi = {10.1007/s12265-025-10620-3}
}
EUVIMED